Fluciclovine PET/CT in Multiple Myeloma Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOslo University Hospital
About this trial
Comparison between image findings at aminoacid PET/CT and FDG PET/CT for myeloma patients
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Multiple myeloma patients suitable for ASCT treatment
Disqualifiers
Patients with contraindications to ASCT treatment
Trial population
Multiple myeloma patients
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Comparing of image findings at PET
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov